 |
|
|
| |
Assessment of risk of acute kidney injury associated with exposure to
sofosbuvir-containing HCV treatment regimens and HCV infection
|
| |
| |
Reported by Jules Levin
AASLD 2016 Nov 11-15 Boston, MA
L Telep, A Brown, DM Brainard, AP Chokkalingam
Gilead Sciences, Inc., Foster City, CA, United States
|
| |
|
|
|
|
|
